Action Merck KGAA - MRK

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R)

First in the Class of Sustained Follicle Stimulants Would Reduce the Number of Treatment Injections for Patients WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Merck & Co., Inc...

Critical Alerts For Merck, Urban Outfitters, Goldcorp, International Paper and Archer Daniels Midland

CHICAGO, Sept. 28 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for MRK, URBN, GG, IP and ADM. Seven Summits Strategic Investments' PriceWatch Alerts are available at...

Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Action Suit With Proposed $41.5 Million

Lawsuit settles claims regarding efficacy and safety of popular prescription drugs. BOSTON, Aug. 5 /PRNewswire/ -- Attorneys representing consumers and third-party payors today announced a...

Seven Summits Research Releases Comments on Apple, Verizon, Merck, Netflix and State Street

CHICAGO, July 20 /PRNewswire/ -- Seven Summits Strategic Investments releases its Stocks To Watch Guide. The Seven Summits Strategic Investments Stocks To Watch Guide (go to:...

The 'Bad', the 'Good' and the 'Other': The Triple Threat of Cardiovascular Disease

PGA TOUR golfer Tom Lehman tees-off Triple Threat Challenge about heart disease and cholesterol education ORLANDO, Fla., Nov. 6 /PRNewswire-FirstCall/ -- More Americans are likely to know their...

Lead Plaintiff Attorney Calls Ruling in Vioxx Case 'A Positive Development' for His Client and Others Suing Merck

NEWPORT BEACH, Calif., Aug. 31 /PRNewswire/ -- In response to Merck's statement Wednesday that the company would seek a new trial on "all liability issues," Mark P. Robinson, Jr., lead plaintiff...

Newport Beach Attorney Announces $51 Million Verdict in Vioxx Case

NEWPORT BEACH, Calif., Aug. 17 /PRNewswire/ -- Today a unanimous eight-man jury in New Orleans rendered a $51,000,000 verdict against Merck & Co., Inc., and its drug Vioxx. This lawsuit arises...

Merck and Bristol-Myers Squibb License New AIDS Drugs to IPM for Development as Microbicides to Protect Women from HIV

New Nature study shows potential of 'entry inhibitor' compounds as HIV prevention tool NEW YORK, Oct. 31 /PRNewswire/ -- In a first-of-its-kind joint announcement, two of the world's leading...

Viles & Beckman, P.A. File Vioxx Class Action in Fort Myers

Viles & Beckman, P.A. File Vioxx Class Action in Fort Myers FORT MYERS, Fla., Oct. 26 /PRNewswire/ -- Viles & Beckman, P.A. filed a class action lawsuit yesterday challenging Merck & Co., Inc...

Johnson & Johnson to Acquire Merck & Co., Inc.'s Interest in European Consumer Pharmaceuticals Joint Venture

Johnson & Johnson to Acquire Merck & Co., Inc.'s Interest in European Consumer Pharmaceuticals Joint Venture NEW BRUNSWICK, N.J. and WHITEHOUSE STATION, N.J., Feb. 27 /PRNewswire- FirstCall/...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

MRK - Frequently Asked Questions (FAQ)

What is the current Merck KGAA share price?

The current share price of Merck KGAA is 0,00 €

What is the 1 year trading range for Merck KGAA share price?

Merck KGAA has traded in the range of 0,00 € to 0,00 € during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
EVAAAAskoll Eva AA	0,034 € (16 900,00%)	1,25k
GSRAAG Rent AA	0,01 € (1 900,00%)	1,5k
WPSQ26Pasquarelli Auto SpA	0,0146 € (33,94%)	145,3k
WRKT25Roket Sharing Company Spa	0,0039 € (30,00%)	27,5k
1FEY2FuelCell Energy Inc	11,60 € (21,53%)	630
WSAC25Saccheria Flli Franceschetti SpA	0,0183 € (-29,62%)	12,1k
WNUS26Nusco Spa	0,1007 € (-25,07%)	16,9k
EPHEPH SpA	0,069 € (-13,75%)	166,31k
1PLUGPlug Power Inc	2,65 € (-13,51%)	61,23k
GTGT Talent Group SpA	2,08 € (-13,33%)	1,5k
TITTelecom Italia SpA	0,2576 € (1,46%)	202,95M
ISPIntesa Sanpaolo Spa	3,9625 € (1,32%)	70,38M
TITRTelecom Italia	0,2992 € (1,01%)	35,54M
SPMSaipem Spa	2,723 € (-0,07%)	31,09M
ENELEnel Spa	6,995 € (0,01%)	27,16M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Merck KGAA (MRK)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

MRK Dernières nouvelles

Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R)

Critical Alerts For Merck, Urban Outfitters, Goldcorp, International Paper and Archer Daniels Midland

Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Action Suit With Proposed $41.5 Million

Seven Summits Research Releases Comments on Apple, Verizon, Merck, Netflix and State Street

The 'Bad', the 'Good' and the 'Other': The Triple Threat of Cardiovascular Disease

Lead Plaintiff Attorney Calls Ruling in Vioxx Case 'A Positive Development' for His Client and Others Suing Merck

Newport Beach Attorney Announces $51 Million Verdict in Vioxx Case

Merck and Bristol-Myers Squibb License New AIDS Drugs to IPM for Development as Microbicides to Protect Women from HIV

Viles & Beckman, P.A. File Vioxx Class Action in Fort Myers

Johnson & Johnson to Acquire Merck & Co., Inc.'s Interest in European Consumer Pharmaceuticals Joint Venture

MRK - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Merck KGAA (MRK) Cours

Merck KGAA (MRK)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

MRK Dernières nouvelles

MRK - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE